Qnomx Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.84M
- Investors
-
7
Qnomx General Information
Description
Provider of cancer genomic analysis services designed to support informed treatment decisions. The company offers expert cancer genomics case review and consultation, leveraging curated data from peer-reviewed literature and a proprietary knowledge base with compliance and security measures such as GDPR compliance and data deletion after service delivery, enabling healthcare providers to access timely, expert analysis and consultation support for precision oncology.
Contact Information
Website
www.qnomx.aiCorporate Office
- C/O Switzerland Innovation Park Basel Area AG
- Lichtstrasse 35
- 4056 Basel
- Switzerland
Corporate Office
- C/O Switzerland Innovation Park Basel Area AG
- Lichtstrasse 35
- 4056 Basel
- Switzerland
Qnomx Timeline
Qnomx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 14-Apr-2025 | $1.84M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 01-Jan-2024 | Completed | Generating Revenue |
Qnomx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Pre-Seed Preferred |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Qnomx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Qnomx Patents
Qnomx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026003128-A1 | Method and system for generating information on a health condition of a patient | Pending | 26-Jun-2024 |
Qnomx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Qnomx Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Becker Ventures | PE/Buyout | Minority | ||
| better ventures (Germany) | Angel Group | Minority | ||
| Heal Capital | Venture Capital | Minority | ||
| Springboard Health Angels | Angel Group | Minority | ||
| Superangels | Venture Capital | Minority |
Qnomx FAQs
-
When was Qnomx founded?
Qnomx was founded in 2022.
-
Where is Qnomx headquartered?
Qnomx is headquartered in Basel, Switzerland.
-
What is the size of Qnomx?
Qnomx has 6 total employees.
-
What industry is Qnomx in?
Qnomx’s primary industry is Hospitals/Inpatient Services.
-
Is Qnomx a private or public company?
Qnomx is a Private company.
-
What is the current valuation of Qnomx?
The current valuation of Qnomx is .
-
What is Qnomx’s current revenue?
The current revenue for Qnomx is .
-
How much funding has Qnomx raised over time?
Qnomx has raised $1.84M.
-
Who are Qnomx’s investors?
Becker Ventures, better ventures (Germany), Heal Capital, Springboard Health Angels, and Superangels are 5 of 7 investors who have invested in Qnomx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
